Literature DB >> 15998517

Plasma levels of oxidized-low-density lipoproteins are higher in patients with unstable angina and correlated with angiographic coronary complex plaques.

Maurizio Anselmi1, Ulisse Garbin, Pierfrancesco Agostoni, Massimiliano Fusaro, Anna Fratta Pasini, Cristina Nava, Dritan Keta, Marco Turri, Piero Zardini, Corrado Vassanelli, Vincenzo Lo Cascio, Luciano Cominacini.   

Abstract

OBJECTIVES: To measure circulating levels of oxidized-low-density lipoproteins (ox-LDL) in patients with stable and unstable angina and controls, and to investigate their correlation with the extent of coronary artery disease (CAD) and the presence of complex plaques at coronary angiography. METHODS AND
RESULTS: Circulating ox-LDL were assessed, using ELISA, in patients with unstable angina (UA, n=26), stable angina (SA, n=29) and in controls (C, n=27). All patients underwent coronary angiography. The extent of CAD was evaluated using a quantitative score, while the presence of complex, vulnerable plaques was angiographically assessed. Ox-LDL were higher in UA patients than in SA patients and in C subjects, and in SA patients than in C subjects (C, 45.6+/-12.8 U/L; SA, 58.8+/-11.0 U/L; UA, 73.7+/-13.6 U/L; p<0.001). No correlation was found with the extent of atherosclerotic disease in the coronary tree. Patients with angiographic complex lesions showed significantly higher levels of ox-LDL (68.4+/-13.9 U/L versus 55.2+/-16.4 U/L, p<0.001). Multiple regression analysis showed that ox-LDL were independent predictors of the presence of complex plaques (p<0.023).
CONCLUSIONS: Ox-LDL levels are higher in unstable patients and correlate with the presence of angiographically documented complex plaques. Ox-LDL might be markers of destabilization of CAD.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15998517     DOI: 10.1016/j.atherosclerosis.2005.05.020

Source DB:  PubMed          Journal:  Atherosclerosis        ISSN: 0021-9150            Impact factor:   5.162


  12 in total

1.  Pro-atherogenic and pro-oxidant crosstalk between adipocytes and macrophages.

Authors:  Lili Nimri; Claudia Grajeda-Iglesias; Nina Volkova; Michael Aviram
Journal:  Eur J Nutr       Date:  2018-05-26       Impact factor: 5.614

2.  Sesamol suppresses the inflammatory response by inhibiting NF-κB/MAPK activation and upregulating AMP kinase signaling in RAW 264.7 macrophages.

Authors:  Xin-Ling Wu; Chian-Jiun Liou; Zih-Ying Li; Xuan-Yu Lai; Li-Wen Fang; Wen-Chung Huang
Journal:  Inflamm Res       Date:  2015-06-10       Impact factor: 4.575

3.  Oxidized low-density lipoprotein and ankle-brachial pressure index in patients with clinically evident peripheral arterial disease.

Authors:  Ruben Miguel Ayzin Rosoky; Nelson Wolosker; Michel Nasser; Antonio Eduardo Zerati; Magnus Gidlund; Pedro Puech-Leão
Journal:  Clinics (Sao Paulo)       Date:  2010-04       Impact factor: 2.365

Review 4.  Endoplasmic Reticulum Stress, NRF2 Signalling and Cardiovascular Diseases in a Nutshell.

Authors:  Chiara Mozzini; Luciano Cominacini; Ulisse Garbin; Anna Maria Fratta Pasini
Journal:  Curr Atheroscler Rep       Date:  2017-08       Impact factor: 5.113

5.  Serum oxidized low-density lipoprotein decreases in response to statin therapy and relates independently to reductions in coronary plaque in patients with HIV.

Authors:  Eric Nou; Michael T Lu; Sara E Looby; Kathleen V Fitch; Elli A Kim; Hang Lee; Udo Hoffmann; Steven K Grinspoon; Janet Lo
Journal:  AIDS       Date:  2016-02-20       Impact factor: 4.177

Review 6.  Evaluating oxidative stress in human cardiovascular disease: methodological aspects and considerations.

Authors:  R Lee; M Margaritis; K M Channon; C Antoniades
Journal:  Curr Med Chem       Date:  2012       Impact factor: 4.530

7.  Oxidative Stress and Inflammation in Heart Disease: Do Antioxidants Have a Role in Treatment and/or Prevention?

Authors:  Fredric J Pashkow
Journal:  Int J Inflam       Date:  2011-08-11

8.  Infliximab improves vascular stiffness in patients with rheumatoid arthritis.

Authors:  M Wong; S P Oakley; L Young; B Y Jiang; A Wierzbicki; G Panayi; P Chowienczyk; B Kirkham
Journal:  Ann Rheum Dis       Date:  2008-10-17       Impact factor: 19.103

Review 9.  Autoantibodies to apolipoprotein A-1 in cardiovascular diseases: current perspectives.

Authors:  P C Teixeira; P Cutler; N Vuilleumier
Journal:  Clin Dev Immunol       Date:  2012-11-20

Review 10.  Oxidative Stress in Cardiovascular Diseases: Involvement of Nrf2 Antioxidant Redox Signaling in Macrophage Foam Cells Formation.

Authors:  Bee Kee Ooi; Bey Hing Goh; Wei Hsum Yap
Journal:  Int J Mol Sci       Date:  2017-11-05       Impact factor: 5.923

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.